Innovation, Materials Science, Biochemistry, Interview.
of AMSilk, a Munich-based company which has raised around €30 million in venture capital. Who owns the rights to the research and how exactly does the commercialization process work? T.S. The basis for starting the company was the IP transfer into the GmbH from my former university, the TU Munich,